Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$27,000.00

CGS-M Application - Imran Syed Ahmed

EF 2024-25

Résumé
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. Glial dysfunction and consequent neuroinflammation has underscored the role of central nervous system (CNS)-resident immune cells like microglia as key contributors to ALS pathology. Immune memory has dogmatically been ascribed to adaptive immunity that provides long-lasting pathogen-specific protection. However, there is growing evidence that the innate immune system can exhibit memory-like recall responses, whereby an initial priming event can alter subsequent inflammatory responses. This process is attributed to epigenetic and metabolic reprogramming of innate immune cells. Additionally, our group has demonstrated that influenza A virus (IAV) infection induced aberrant microglia activation and accelerated ALS progression in SOD1G93A mice. Notably, this indicated that IAV infection can have distal implications within the CNS. However, it remains unknown if IAV infection causes durable metabolic and epigenetic perturbations in microglia, contributing to accelerated ALS pathogenesis. Thus, we hypothesize that IAV infection exacerbates ALS progression through metabolic and epigenetic rewiring of microglia. We aim to characterize the metabolic and epigenetic profile of microglia in the CNS of SOD1G93A mice following an acute viral infection from IAV. In addition, we will also characterize the impact of therapeutics that have been used to ameliorate neuropathology in ALS and Alzheimer's mouse models on the epigenetic and metabolic profiles of microglia from SOD1G93A mice infected with IAV.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530367
Name
Ahmed Imran S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
CGS-M Application - Imran Syed Ahmed
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Accelerated Disease Progression; Acute Viral Infection; Amyotrophic Lateral Sclerosis; Hind-Limb Weakness; Immune Memory; Lumbar Spine; Microglia; Neuroinflammation; Neuromuscular Disease
Abstract
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. Glial dysfunction and consequent neuroinflammation has underscored the role of central nervous system (CNS)-resident immune cells like microglia as key contributors to ALS pathology. Immune memory has dogmatically been ascribed to adaptive immunity that provides long-lasting pathogen-specific protection. However, there is growing evidence that the innate immune system can exhibit memory-like recall responses, whereby an initial priming event can alter subsequent inflammatory responses. This process is attributed to epigenetic and metabolic reprogramming of innate immune cells. Additionally, our group has demonstrated that influenza A virus (IAV) infection induced aberrant microglia activation and accelerated ALS progression in SOD1G93A mice. Notably, this indicated that IAV infection can have distal implications within the CNS. However, it remains unknown if IAV infection causes durable metabolic and epigenetic perturbations in microglia, contributing to accelerated ALS pathogenesis. Thus, we hypothesize that IAV infection exacerbates ALS progression through metabolic and epigenetic rewiring of microglia. We aim to characterize the metabolic and epigenetic profile of microglia in the CNS of SOD1G93A mice following an acute viral infection from IAV. In addition, we will also characterize the impact of therapeutics that have been used to ameliorate neuropathology in ALS and Alzheimer's mouse models on the epigenetic and metabolic profiles of microglia from SOD1G93A mice infected with IAV.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Imran S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~